Product NDC: | 49884-501 |
Proprietary Name: | Budesonide |
Non Proprietary Name: | Budesonide |
Active Ingredient(s): | 3 mg/1 & nbsp; Budesonide |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 49884-501 |
Labeler Name: | Par Pharmaceutical Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021324 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20110818 |
Package NDC: | 49884-501-01 |
Package Description: | 100 CAPSULE in 1 BOTTLE (49884-501-01) |
NDC Code | 49884-501-01 |
Proprietary Name | Budesonide |
Package Description | 100 CAPSULE in 1 BOTTLE (49884-501-01) |
Product NDC | 49884-501 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Budesonide |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20110818 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Par Pharmaceutical Inc. |
Substance Name | BUDESONIDE |
Strength Number | 3 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |